treated streptozotocin-induced DM rats with exenatide, a GLP-1R agonist, for 8 weeks and found that exenatide treatment attenuated the reduction in motor nerve conduction velocity and paw intraepidermal fibre density (50). Here, GLP1R is linked to diabetes mellitus.